临床试验

Intravenous Neonatal Central Access Safety Trial

NCT：NCT05537389 · COMPLETED

NCT编号NCT05537389

状态COMPLETED

开始日期2023-01-01

完成时间2026-09-07

SponsorUniversity of Turin, Italy (OTHER)

First posted2022-09-13

Last updated2026-09-16

简要摘要

Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU). In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated. In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。